Novel Cell Cytometers: Need of the Hour
The domain of novel cell cytometers has attracted much attention of within the global biopharmaceutical industry in recent years. This popularity can be attributed mainly to the need of these tools to address the rising prevalence of chronic disease conditions. Cell cytometers allow for the simultaneous characterization of cells from a mixed population, thereby helping in further analyzing the underlying disease condition. This cutting-edge technique has been able to drive significant application and innovation in understanding the underlying causes of primary immune deficiency disorders and their prognostic procedures.
In fact, over the years, the cell cytometry domain has evolved to incorporate novel types of cytometers that offer several advantages over the conventional cell cytometers. Their popularity can be attributed to various factors, such as rapid diagnosis, high resolution of results, and multi-disciplinary applications such as immunology, virology, molecular biology, cancer biology and infectious disease monitoring. These novel categories include high throughput flow cytometers and image cytometers. It is worth highlighting that in the field of research and drug development, high throughput flow cytometry (HTFC) has played a major role through its rapid automated testing. In fact, high throughput flow cytometers are used for phenotypic screening, antibody screening, lead optimization and multiplex compound profiling, enabling the measurement of several endpoints at once. On the other hand, image cytometers have the ability to offer better resolution as compared to traditional flow cytometric techniques, which records signals produced by whole cells.
Industry Stakeholders Are Striking Partnerships to Strengthen Their Product Portfolio
With the growing adoption of novel cell cytometers, several industry players have signed multiple agreements for high throughput flow cytometers and image cytometers.
Likely Growth of the Novel Cell Cytometry Market
During our research, we estimated the market under conservative, base and optimistic scenarios. As per the base case forecast scenario, market for cell cytometry is estimated to grow at an annualized rate of ~10%, in the given time period. The opportunity is likely to be well distributed across type of cytometer, company size and geographical regions.
It is worth highlighting that there is a significant rise in the interest of stakeholders in cell cytometry segment; this can be validated by the increase in partnership activity within this domain. Further, the growing demand for high throughput screening has compelled the players engaged in this domain to expand their existing capabilities / capacities in order to accommodate the future needs of their clients.
You can get more exhaustive INSIGHTS on this topic by reading the report summary published by Roots Analysis on the link here https://www.rootsanalysis.com/reports/cell-cytometry-market.html